Home › Steatotische leveraandoening › Arizona › Chandler
Steatotische leveraandoening klinische studies in Chandler, AZ
10 studies voor Steatotische leveraandoening zoeken deelnemers op locaties in en rond Chandler (binnen ongeveer 30 mijl). Open een studie om te zien wie er kan deelnemen en hoe je contact opneemt met het studieteam.
Officiële studietekst (Engels)
Rekruteren voor een studie? Laat deze bovenaan deze pagina verschijnen — $99 voor 30 dagen →
A Study to Evaluate the Efficacy and Safety of Pegozafermin in Participants With Compensated Cirrhosis Due to MASH
RekruterenFase 3
- 89bio Clinical Study Site, Chandler
A Study Evaluating the Efficacy and Safety of Pegozafermin in Participants With MASH and Fibrosis (ENLIGHTEN-Fibrosis)
RekruterenFase 3
- 89bio Clinical Study Site, Chandler
A Precision Medicine Approach Using Gene Silencing to Treat a Chronic Liver Disease Called Metabolic Dysfunction-Associated Steatohepatitis (MASH) in Adult Participants at Increased Genetic Risk for This Condition
RekruterenFase 2
- Arizona Liver Health, Chandler
A Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes)
RekruterenFase 3
- The Institute for Liver Health II dba Arizona Clinical Trials - Chandler, Chandler
A Study Evaluating Efruxifermin in Subjects With Compensated Cirrhosis Due to NASH/MASH
RekruterenFase 3
- Akero Clinical Study Site, Chandler
A Study of a Thyroid Hormone Receptor Beta Isoform (THRβ) Agonist and an Semicarbazide Sensitive Amine Oxidase (SSAO) Inhibitor, Alone and in Combination, in Adults With Presumed Metabolic Dysfunction-associated Steatohepatitis (MASH)
RekruterenFase 2
- Arizona Liver Health, Chandler
A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease
RekruterenFase 2
- GSK Investigational Site, Chandler
A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH
RekruterenFase 3
- GSK Investigational Site, Chandler
A Study of Efimosfermin Alfa in Participants With Biopsy-confirmed Cirrhosis (Compensated) Due to MASH
RekruterenFase 2
- GSK Investigational Site, Chandler
Non-Invasive Quantification of Liver Health in NASH (N-QUAN)
Rekruteren
- Arizona Liver Health, Chandler
Steatotische leveraandoening studies in andere steden
- San Antonio, TX17 studies
- New York City, NY16 studies
- Miami, FL16 studies
- San Diego, CA14 studies
- Austin, TX13 studies
- Houston, TX13 studies
- Richmond, VA12 studies
- Tucson, AZ10 studies
- Hialeah, FL9 studies
- Dallas, TX9 studies
- Orlando, FL9 studies
- St. Louis, MO9 studies
Andere studies in Chandler
- Borstkanker5 studies
- Niet-kleincellige longkanker5 studies
- Colorectale kanker5 studies
- Obesitas5 studies
- Spijsverteringsziekten5 studies
- Leveraandoeningen4 studies
- Overgewicht4 studies
- Type 2-diabetes4 studies
- Metastatische kanker4 studies
- Ziekte van Alzheimer3 studies
- Cardiovasculaire ziekte3 studies
- Dikkedarmkanker3 studies
Van ClinicalTrials.gov, gegevens opgehaald op 6 okt. 2026. Elke studie stelt eigen deelnamecriteria vast; het studieteam bepaalt wie er kan deelnemen.